CFTR and cystic fibrosis: Cystic fibrosis (CF) was once a fatal disease of childhood, but with advances in combination CF transmembrane conductance regulator (CFTR) modulator therapies, children born with CF between 2019 and 2023 have a median predicted life expectancy of 61 years, nearly doubling over the past two decades [1].